Physician profile
Marcus L Brown
NPI 1437198603
$10,085.36
in general payments reported to CMS, 2019-2025
45 companies · $1,156 in 2025
The $1,156 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,347 · 2020: $1,018 · 2021: $1,900 · 2022: $1,158 · 2023: $1,671 · 2024: $1,836 · 2025: $1,156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,662.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,487.21 | 2019-2024 | Lifevest |
| Amgen INC. | $928.34 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $771.16 | 2019-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $593.02 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $588.99 | 2019-2024 | Xarelto |
| Pfizer INC. | $535.28 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $506.58 | 2020-2025 | Farxiga, Wainua |
| Shockwave Medical, INC | $470.72 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $361.25 | 2021-2025 | Mitraclip |
| Medtronic, INC. | $355.09 | 2021-2023 | Micra, Onyx Frontier |
| Edwards Lifesciences Corporation | $353.45 | 2020-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Medtronic Vascular, INC. | $317.57 | 2019 | |
| Teleflex LLC | $283.94 | 2020-2022 | |
| Esperion Therapeutics, INC. | $265.99 | 2020-2025 | Nexletol |
| Abiomed | $250.46 | 2021-2025 | Impella |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.